Molecular	O
profile	O
of	O
5	B:C0016360
-	I:C0016360
fluorouracil	I:C0016360
pathway	O
genes	O
in	O
colorectal	O
carcinoma	I:C0009402
.	O

Molecular	O
profile	O
of	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
pathway	B:C1704259
genes	O
in	O
colorectal	O
carcinoma	I:C0009402
.	O

Molecular	O
profile	O
of	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
pathway	O
genes	B:C0017337
in	O
colorectal	O
carcinoma	I:C0009402
.	O

Molecular	O
profile	O
of	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
pathway	O
genes	O
in	O
colorectal	B:C0009402
carcinoma	I:C0009402
.	O

This	O
study	B:C2603343
addresses	O
involvement	O
of	O
major	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
(	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
)	O
pathway	O
genes	O
in	O
the	O
prognosis	O
of	O
colorectal	O
carcinoma	I:C0009402
patients	O
.	O

This	O
study	O
addresses	O
involvement	O
of	O
major	O
5	B:C0016360
-	I:C0016360
fluorouracil	I:C0016360
(	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
)	O
pathway	O
genes	O
in	O
the	O
prognosis	O
of	O
colorectal	O
carcinoma	I:C0009402
patients	O
.	O

This	O
study	O
addresses	O
involvement	O
of	O
major	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
(	O
5	B:C0016360
-	I:C0016360
fluorouracil	I:C0016360
)	O
pathway	O
genes	O
in	O
the	O
prognosis	O
of	O
colorectal	O
carcinoma	I:C0009402
patients	O
.	O

This	O
study	O
addresses	O
involvement	O
of	O
major	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
(	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
)	O
pathway	B:C1704259
genes	O
in	O
the	O
prognosis	O
of	O
colorectal	O
carcinoma	I:C0009402
patients	O
.	O

This	O
study	O
addresses	O
involvement	O
of	O
major	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
(	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
)	O
pathway	O
genes	B:C0017337
in	O
the	O
prognosis	O
of	O
colorectal	O
carcinoma	I:C0009402
patients	O
.	O

This	O
study	O
addresses	O
involvement	O
of	O
major	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
(	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
)	O
pathway	O
genes	O
in	O
the	O
prognosis	B:C0033325
of	O
colorectal	O
carcinoma	I:C0009402
patients	O
.	O

This	O
study	O
addresses	O
involvement	O
of	O
major	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
(	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
)	O
pathway	O
genes	O
in	O
the	O
prognosis	O
of	O
colorectal	B:C0009402
carcinoma	I:C0009402
patients	O
.	O

Testing	B:C0150098
set	I:C0150098
and	O
two	O
validation	O
sets	I:C0282574
comprising	O
paired	O
tumor	O
and	O
adjacent	O
mucosa	O
tissue	I:C0026724
samples	O
from	O
151	O
patients	O
were	O
used	O
for	O
transcript	O
profiling	O
of	O
15	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
pathway	O
genes	O
by	O
quantitative	O
real	I:C3179034
-	I:C3179034
time	I:C3179034
PCR	I:C3179034
and	O
DNA	O
methylation	I:C1880239
profiling	I:C1880239
by	O
high	O
resolution	O
melting	O
analysis	O
.	O

Testing	O
set	I:C0150098
and	O
two	O
validation	B:C0282574
sets	I:C0282574
comprising	O
paired	O
tumor	O
and	O
adjacent	O
mucosa	O
tissue	I:C0026724
samples	O
from	O
151	O
patients	O
were	O
used	O
for	O
transcript	O
profiling	O
of	O
15	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
pathway	O
genes	O
by	O
quantitative	O
real	I:C3179034
-	I:C3179034
time	I:C3179034
PCR	I:C3179034
and	O
DNA	O
methylation	I:C1880239
profiling	I:C1880239
by	O
high	O
resolution	O
melting	O
analysis	O
.	O

Testing	O
set	I:C0150098
and	O
two	O
validation	O
sets	I:C0282574
comprising	O
paired	O
tumor	B:C0027651
and	O
adjacent	O
mucosa	O
tissue	I:C0026724
samples	O
from	O
151	O
patients	O
were	O
used	O
for	O
transcript	O
profiling	O
of	O
15	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
pathway	O
genes	O
by	O
quantitative	O
real	I:C3179034
-	I:C3179034
time	I:C3179034
PCR	I:C3179034
and	O
DNA	O
methylation	I:C1880239
profiling	I:C1880239
by	O
high	O
resolution	O
melting	O
analysis	O
.	O

Testing	O
set	I:C0150098
and	O
two	O
validation	O
sets	I:C0282574
comprising	O
paired	O
tumor	O
and	O
adjacent	B:C0205117
mucosa	O
tissue	I:C0026724
samples	O
from	O
151	O
patients	O
were	O
used	O
for	O
transcript	O
profiling	O
of	O
15	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
pathway	O
genes	O
by	O
quantitative	O
real	I:C3179034
-	I:C3179034
time	I:C3179034
PCR	I:C3179034
and	O
DNA	O
methylation	I:C1880239
profiling	I:C1880239
by	O
high	O
resolution	O
melting	O
analysis	O
.	O

Testing	O
set	I:C0150098
and	O
two	O
validation	O
sets	I:C0282574
comprising	O
paired	O
tumor	O
and	O
adjacent	O
mucosa	B:C0026724
tissue	I:C0026724
samples	O
from	O
151	O
patients	O
were	O
used	O
for	O
transcript	O
profiling	O
of	O
15	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
pathway	O
genes	O
by	O
quantitative	O
real	I:C3179034
-	I:C3179034
time	I:C3179034
PCR	I:C3179034
and	O
DNA	O
methylation	I:C1880239
profiling	I:C1880239
by	O
high	O
resolution	O
melting	O
analysis	O
.	O

Testing	O
set	I:C0150098
and	O
two	O
validation	O
sets	I:C0282574
comprising	O
paired	O
tumor	O
and	O
adjacent	O
mucosa	O
tissue	I:C0026724
samples	O
from	O
151	O
patients	O
were	O
used	O
for	O
transcript	B:C1519595
profiling	O
of	O
15	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
pathway	O
genes	O
by	O
quantitative	O
real	I:C3179034
-	I:C3179034
time	I:C3179034
PCR	I:C3179034
and	O
DNA	O
methylation	I:C1880239
profiling	I:C1880239
by	O
high	O
resolution	O
melting	O
analysis	O
.	O

Testing	O
set	I:C0150098
and	O
two	O
validation	O
sets	I:C0282574
comprising	O
paired	O
tumor	O
and	O
adjacent	O
mucosa	O
tissue	I:C0026724
samples	O
from	O
151	O
patients	O
were	O
used	O
for	O
transcript	O
profiling	B:C0079247
of	O
15	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
pathway	O
genes	O
by	O
quantitative	O
real	I:C3179034
-	I:C3179034
time	I:C3179034
PCR	I:C3179034
and	O
DNA	O
methylation	I:C1880239
profiling	I:C1880239
by	O
high	O
resolution	O
melting	O
analysis	O
.	O

Testing	O
set	I:C0150098
and	O
two	O
validation	O
sets	I:C0282574
comprising	O
paired	O
tumor	O
and	O
adjacent	O
mucosa	O
tissue	I:C0026724
samples	O
from	O
151	O
patients	O
were	O
used	O
for	O
transcript	O
profiling	O
of	O
15	O
5	B:C0016360
-	I:C0016360
fluorouracil	I:C0016360
pathway	O
genes	O
by	O
quantitative	O
real	I:C3179034
-	I:C3179034
time	I:C3179034
PCR	I:C3179034
and	O
DNA	O
methylation	I:C1880239
profiling	I:C1880239
by	O
high	O
resolution	O
melting	O
analysis	O
.	O

Testing	O
set	I:C0150098
and	O
two	O
validation	O
sets	I:C0282574
comprising	O
paired	O
tumor	O
and	O
adjacent	O
mucosa	O
tissue	I:C0026724
samples	O
from	O
151	O
patients	O
were	O
used	O
for	O
transcript	O
profiling	O
of	O
15	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
pathway	B:C1704259
genes	O
by	O
quantitative	O
real	I:C3179034
-	I:C3179034
time	I:C3179034
PCR	I:C3179034
and	O
DNA	O
methylation	I:C1880239
profiling	I:C1880239
by	O
high	O
resolution	O
melting	O
analysis	O
.	O

Testing	O
set	I:C0150098
and	O
two	O
validation	O
sets	I:C0282574
comprising	O
paired	O
tumor	O
and	O
adjacent	O
mucosa	O
tissue	I:C0026724
samples	O
from	O
151	O
patients	O
were	O
used	O
for	O
transcript	O
profiling	O
of	O
15	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
pathway	O
genes	B:C0017337
by	O
quantitative	O
real	I:C3179034
-	I:C3179034
time	I:C3179034
PCR	I:C3179034
and	O
DNA	O
methylation	I:C1880239
profiling	I:C1880239
by	O
high	O
resolution	O
melting	O
analysis	O
.	O

Testing	O
set	I:C0150098
and	O
two	O
validation	O
sets	I:C0282574
comprising	O
paired	O
tumor	O
and	O
adjacent	O
mucosa	O
tissue	I:C0026724
samples	O
from	O
151	O
patients	O
were	O
used	O
for	O
transcript	O
profiling	O
of	O
15	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
pathway	O
genes	O
by	O
quantitative	B:C3179034
real	I:C3179034
-	I:C3179034
time	I:C3179034
PCR	I:C3179034
and	O
DNA	O
methylation	I:C1880239
profiling	I:C1880239
by	O
high	O
resolution	O
melting	O
analysis	O
.	O

Testing	O
set	I:C0150098
and	O
two	O
validation	O
sets	I:C0282574
comprising	O
paired	O
tumor	O
and	O
adjacent	O
mucosa	O
tissue	I:C0026724
samples	O
from	O
151	O
patients	O
were	O
used	O
for	O
transcript	O
profiling	O
of	O
15	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
pathway	O
genes	O
by	O
quantitative	O
real	I:C3179034
-	I:C3179034
time	I:C3179034
PCR	I:C3179034
and	O
DNA	B:C1880239
methylation	I:C1880239
profiling	I:C1880239
by	O
high	O
resolution	O
melting	O
analysis	O
.	O

Intratumoral	B:C1517564
molecular	O
profiles	O
were	O
correlated	O
with	O
clinical	O
data	I:C1516606
of	O
patients	O
.	O

Intratumoral	O
molecular	O
profiles	O
were	O
correlated	O
with	O
clinical	B:C1516606
data	I:C1516606
of	O
patients	O
.	O

Protein	B:C0428479
levels	I:C0428479
of	O
two	O
most	O
relevant	O
candidate	O
markers	O
were	O
assessed	O
by	O
immunoblotting	O
.	O

Protein	O
levels	I:C0428479
of	O
two	O
most	O
relevant	O
candidate	O
markers	B:C0005516
were	O
assessed	O
by	O
immunoblotting	O
.	O

Protein	O
levels	I:C0428479
of	O
two	O
most	O
relevant	O
candidate	O
markers	O
were	O
assessed	O
by	O
immunoblotting	B:C0020985
.	O

Downregulation	B:C0013081
of	O
DPYD	O
and	O
upregulation	O
of	O
PPAT	O
,	O
UMPS	O
,	O
RRM2	O
,	O
and	O
SLC29A1	O
transcripts	O
were	O
found	O
in	O
tumors	O
compared	O
to	O
adjacent	O
mucosa	O
in	O
testing	O
and	O
validation	O
sets	I:C0282574
of	O
patients	O
.	O

Downregulation	O
of	O
DPYD	B:C1366555
and	O
upregulation	O
of	O
PPAT	O
,	O
UMPS	O
,	O
RRM2	O
,	O
and	O
SLC29A1	O
transcripts	O
were	O
found	O
in	O
tumors	O
compared	O
to	O
adjacent	O
mucosa	O
in	O
testing	O
and	O
validation	O
sets	I:C0282574
of	O
patients	O
.	O

Downregulation	O
of	O
DPYD	O
and	O
upregulation	B:C0041904
of	O
PPAT	O
,	O
UMPS	O
,	O
RRM2	O
,	O
and	O
SLC29A1	O
transcripts	O
were	O
found	O
in	O
tumors	O
compared	O
to	O
adjacent	O
mucosa	O
in	O
testing	O
and	O
validation	O
sets	I:C0282574
of	O
patients	O
.	O

Downregulation	O
of	O
DPYD	O
and	O
upregulation	O
of	O
PPAT	B:C1418780
,	O
UMPS	O
,	O
RRM2	O
,	O
and	O
SLC29A1	O
transcripts	O
were	O
found	O
in	O
tumors	O
compared	O
to	O
adjacent	O
mucosa	O
in	O
testing	O
and	O
validation	O
sets	I:C0282574
of	O
patients	O
.	O

Downregulation	O
of	O
DPYD	O
and	O
upregulation	O
of	O
PPAT	O
,	O
UMPS	B:C1421354
,	O
RRM2	O
,	O
and	O
SLC29A1	O
transcripts	O
were	O
found	O
in	O
tumors	O
compared	O
to	O
adjacent	O
mucosa	O
in	O
testing	O
and	O
validation	O
sets	I:C0282574
of	O
patients	O
.	O

Downregulation	O
of	O
DPYD	O
and	O
upregulation	O
of	O
PPAT	O
,	O
UMPS	O
,	O
RRM2	B:C1335649
,	O
and	O
SLC29A1	O
transcripts	O
were	O
found	O
in	O
tumors	O
compared	O
to	O
adjacent	O
mucosa	O
in	O
testing	O
and	O
validation	O
sets	I:C0282574
of	O
patients	O
.	O

Downregulation	O
of	O
DPYD	O
and	O
upregulation	O
of	O
PPAT	O
,	O
UMPS	O
,	O
RRM2	O
,	O
and	O
SLC29A1	B:C1420171
transcripts	O
were	O
found	O
in	O
tumors	O
compared	O
to	O
adjacent	O
mucosa	O
in	O
testing	O
and	O
validation	O
sets	I:C0282574
of	O
patients	O
.	O

Downregulation	O
of	O
DPYD	O
and	O
upregulation	O
of	O
PPAT	O
,	O
UMPS	O
,	O
RRM2	O
,	O
and	O
SLC29A1	O
transcripts	B:C1519595
were	O
found	O
in	O
tumors	O
compared	O
to	O
adjacent	O
mucosa	O
in	O
testing	O
and	O
validation	O
sets	I:C0282574
of	O
patients	O
.	O

Downregulation	O
of	O
DPYD	O
and	O
upregulation	O
of	O
PPAT	O
,	O
UMPS	O
,	O
RRM2	O
,	O
and	O
SLC29A1	O
transcripts	O
were	O
found	O
in	O
tumors	B:C0027651
compared	O
to	O
adjacent	O
mucosa	O
in	O
testing	O
and	O
validation	O
sets	I:C0282574
of	O
patients	O
.	O

Downregulation	O
of	O
DPYD	O
and	O
upregulation	O
of	O
PPAT	O
,	O
UMPS	O
,	O
RRM2	O
,	O
and	O
SLC29A1	O
transcripts	O
were	O
found	O
in	O
tumors	O
compared	O
to	O
adjacent	B:C0205117
mucosa	O
in	O
testing	O
and	O
validation	O
sets	I:C0282574
of	O
patients	O
.	O

Downregulation	O
of	O
DPYD	O
and	O
upregulation	O
of	O
PPAT	O
,	O
UMPS	O
,	O
RRM2	O
,	O
and	O
SLC29A1	O
transcripts	O
were	O
found	O
in	O
tumors	O
compared	O
to	O
adjacent	O
mucosa	B:C0026724
in	O
testing	O
and	O
validation	O
sets	I:C0282574
of	O
patients	O
.	O

Downregulation	O
of	O
DPYD	O
and	O
upregulation	O
of	O
PPAT	O
,	O
UMPS	O
,	O
RRM2	O
,	O
and	O
SLC29A1	O
transcripts	O
were	O
found	O
in	O
tumors	O
compared	O
to	O
adjacent	O
mucosa	O
in	O
testing	B:C0150098
and	O
validation	O
sets	I:C0282574
of	O
patients	O
.	O

Downregulation	O
of	O
DPYD	O
and	O
upregulation	O
of	O
PPAT	O
,	O
UMPS	O
,	O
RRM2	O
,	O
and	O
SLC29A1	O
transcripts	O
were	O
found	O
in	O
tumors	O
compared	O
to	O
adjacent	O
mucosa	O
in	O
testing	O
and	O
validation	B:C0282574
sets	I:C0282574
of	O
patients	O
.	O

Low	O
RRM2	B:C1335649
transcript	O
level	O
significantly	O
associated	O
with	O
poor	O
response	O
to	O
the	O
first	O
-	O
line	O
palliative	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
-	O
based	O
chemotherapy	O
in	O
the	O
testing	O
set	I:C0150098
and	O
with	O
poor	O
disease	O
-	O
free	O
interval	O
of	O
patients	O
in	O
the	O
validation	O
set	I:C0282574
irrespective	O
of	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
treatment	O
.	O

Low	O
RRM2	O
transcript	B:C1519595
level	O
significantly	O
associated	O
with	O
poor	O
response	O
to	O
the	O
first	O
-	O
line	O
palliative	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
-	O
based	O
chemotherapy	O
in	O
the	O
testing	O
set	I:C0150098
and	O
with	O
poor	O
disease	O
-	O
free	O
interval	O
of	O
patients	O
in	O
the	O
validation	O
set	I:C0282574
irrespective	O
of	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
treatment	O
.	O

Low	O
RRM2	O
transcript	O
level	O
significantly	O
associated	O
with	O
poor	O
response	O
to	O
the	O
first	O
-	O
line	O
palliative	O
5	B:C0016360
-	I:C0016360
fluorouracil	I:C0016360
-	O
based	O
chemotherapy	O
in	O
the	O
testing	O
set	I:C0150098
and	O
with	O
poor	O
disease	O
-	O
free	O
interval	O
of	O
patients	O
in	O
the	O
validation	O
set	I:C0282574
irrespective	O
of	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
treatment	O
.	O

Low	O
RRM2	O
transcript	O
level	O
significantly	O
associated	O
with	O
poor	O
response	O
to	O
the	O
first	O
-	O
line	O
palliative	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
-	O
based	O
chemotherapy	B:C3665472
in	O
the	O
testing	O
set	I:C0150098
and	O
with	O
poor	O
disease	O
-	O
free	O
interval	O
of	O
patients	O
in	O
the	O
validation	O
set	I:C0282574
irrespective	O
of	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
treatment	O
.	O

Low	O
RRM2	O
transcript	O
level	O
significantly	O
associated	O
with	O
poor	O
response	O
to	O
the	O
first	O
-	O
line	O
palliative	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
-	O
based	O
chemotherapy	O
in	O
the	O
testing	B:C0150098
set	I:C0150098
and	O
with	O
poor	O
disease	O
-	O
free	O
interval	O
of	O
patients	O
in	O
the	O
validation	O
set	I:C0282574
irrespective	O
of	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
treatment	O
.	O

Low	O
RRM2	O
transcript	O
level	O
significantly	O
associated	O
with	O
poor	O
response	O
to	O
the	O
first	O
-	O
line	O
palliative	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
-	O
based	O
chemotherapy	O
in	O
the	O
testing	O
set	I:C0150098
and	O
with	O
poor	O
disease	O
-	O
free	O
interval	O
of	O
patients	O
in	O
the	O
validation	B:C0282574
set	I:C0282574
irrespective	O
of	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
treatment	O
.	O

Low	O
RRM2	O
transcript	O
level	O
significantly	O
associated	O
with	O
poor	O
response	O
to	O
the	O
first	O
-	O
line	O
palliative	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
-	O
based	O
chemotherapy	O
in	O
the	O
testing	O
set	I:C0150098
and	O
with	O
poor	O
disease	O
-	O
free	O
interval	O
of	O
patients	O
in	O
the	O
validation	O
set	I:C0282574
irrespective	O
of	O
5	B:C0016360
-	I:C0016360
fluorouracil	I:C0016360
treatment	O
.	O

Low	O
RRM2	O
transcript	O
level	O
significantly	O
associated	O
with	O
poor	O
response	O
to	O
the	O
first	O
-	O
line	O
palliative	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
-	O
based	O
chemotherapy	O
in	O
the	O
testing	O
set	I:C0150098
and	O
with	O
poor	O
disease	O
-	O
free	O
interval	O
of	O
patients	O
in	O
the	O
validation	O
set	I:C0282574
irrespective	O
of	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
treatment	B:C0087111
.	O

UPP2	B:C1427883
was	O
strongly	O
methylated	O
while	O
its	O
transcript	O
absent	O
in	O
both	O
tumors	O
and	O
adjacent	O
mucosa	O
.	O

UPP2	O
was	O
strongly	O
methylated	O
while	O
its	O
transcript	B:C1519595
absent	O
in	O
both	O
tumors	O
and	O
adjacent	O
mucosa	O
.	O

UPP2	O
was	O
strongly	O
methylated	O
while	O
its	O
transcript	O
absent	O
in	O
both	O
tumors	B:C0027651
and	O
adjacent	O
mucosa	O
.	O

UPP2	O
was	O
strongly	O
methylated	O
while	O
its	O
transcript	O
absent	O
in	O
both	O
tumors	O
and	O
adjacent	B:C0205117
mucosa	O
.	O

UPP2	O
was	O
strongly	O
methylated	O
while	O
its	O
transcript	O
absent	O
in	O
both	O
tumors	O
and	O
adjacent	O
mucosa	B:C0026724
.	O

DPYS	B:C1414144
methylation	O
level	O
was	O
significantly	O
higher	O
in	O
tumor	O
tissues	I:C0475358
compared	O
to	O
adjacent	O
mucosa	O
samples	O
.	O

DPYS	O
methylation	B:C0376452
level	O
was	O
significantly	O
higher	O
in	O
tumor	O
tissues	I:C0475358
compared	O
to	O
adjacent	O
mucosa	O
samples	O
.	O

DPYS	O
methylation	O
level	O
was	O
significantly	O
higher	O
in	O
tumor	B:C0475358
tissues	I:C0475358
compared	O
to	O
adjacent	O
mucosa	O
samples	O
.	O

DPYS	O
methylation	O
level	O
was	O
significantly	O
higher	O
in	O
tumor	O
tissues	I:C0475358
compared	O
to	O
adjacent	B:C0205117
mucosa	O
samples	O
.	O

DPYS	O
methylation	O
level	O
was	O
significantly	O
higher	O
in	O
tumor	O
tissues	I:C0475358
compared	O
to	O
adjacent	O
mucosa	B:C0026724
samples	O
.	O

Low	O
intratumoral	B:C1517564
level	O
of	O
UPB1	O
methylation	O
was	O
prognostic	O
for	O
poor	O
disease	O
-	O
free	O
interval	O
of	O
the	O
patients	O
(	O
P	O
=	O
0.0002	O
)	O
.	O

Low	O
intratumoral	O
level	O
of	O
UPB1	B:C1424165
methylation	O
was	O
prognostic	O
for	O
poor	O
disease	O
-	O
free	O
interval	O
of	O
the	O
patients	O
(	O
P	O
=	O
0.0002	O
)	O
.	O

Low	O
intratumoral	O
level	O
of	O
UPB1	O
methylation	B:C0376452
was	O
prognostic	O
for	O
poor	O
disease	O
-	O
free	O
interval	O
of	O
the	O
patients	O
(	O
P	O
=	O
0.0002	O
)	O
.	O

Low	O
intratumoral	O
level	O
of	O
UPB1	O
methylation	O
was	O
prognostic	B:C0220901
for	O
poor	O
disease	O
-	O
free	O
interval	O
of	O
the	O
patients	O
(	O
P	O
=	O
0.0002	O
)	O
.	O

The	O
rest	O
of	O
the	O
studied	O
5	B:C0016360
-	I:C0016360
fluorouracil	I:C0016360
genes	O
were	O
not	O
methylated	O
in	O
tumors	O
or	O
adjacent	O
mucosa	O
.	O

The	O
rest	O
of	O
the	O
studied	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
genes	B:C0017337
were	O
not	O
methylated	O
in	O
tumors	O
or	O
adjacent	O
mucosa	O
.	O

The	O
rest	O
of	O
the	O
studied	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
genes	O
were	O
not	O
methylated	O
in	O
tumors	B:C0027651
or	O
adjacent	O
mucosa	O
.	O

The	O
rest	O
of	O
the	O
studied	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
genes	O
were	O
not	O
methylated	O
in	O
tumors	O
or	O
adjacent	B:C0205117
mucosa	O
.	O

The	O
rest	O
of	O
the	O
studied	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
genes	O
were	O
not	O
methylated	O
in	O
tumors	O
or	O
adjacent	O
mucosa	B:C0026724
.	O

The	O
observed	O
overexpression	B:C0017262
of	O
several	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
activating	O
genes	I:C0017337
and	O
DPYD	O
downregulation	O
deduce	O
that	O
chemotherapy	O
naïve	O
colorectal	I:C0009404
tumors	I:C0009404
share	O
favorable	O
gene	O
expression	O
profile	O
for	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
therapy	O
.	O

The	O
observed	O
overexpression	O
of	O
several	O
5	B:C0016360
-	I:C0016360
fluorouracil	I:C0016360
activating	O
genes	I:C0017337
and	O
DPYD	O
downregulation	O
deduce	O
that	O
chemotherapy	O
naïve	O
colorectal	I:C0009404
tumors	I:C0009404
share	O
favorable	O
gene	O
expression	O
profile	O
for	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
therapy	O
.	O

The	O
observed	O
overexpression	O
of	O
several	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
activating	B:C0017337
genes	I:C0017337
and	O
DPYD	O
downregulation	O
deduce	O
that	O
chemotherapy	O
naïve	O
colorectal	I:C0009404
tumors	I:C0009404
share	O
favorable	O
gene	O
expression	O
profile	O
for	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
therapy	O
.	O

The	O
observed	O
overexpression	O
of	O
several	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
activating	O
genes	I:C0017337
and	O
DPYD	B:C1366555
downregulation	O
deduce	O
that	O
chemotherapy	O
naïve	O
colorectal	I:C0009404
tumors	I:C0009404
share	O
favorable	O
gene	O
expression	O
profile	O
for	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
therapy	O
.	O

The	O
observed	O
overexpression	O
of	O
several	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
activating	O
genes	I:C0017337
and	O
DPYD	O
downregulation	B:C0013081
deduce	O
that	O
chemotherapy	O
naïve	O
colorectal	I:C0009404
tumors	I:C0009404
share	O
favorable	O
gene	O
expression	O
profile	O
for	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
therapy	O
.	O

The	O
observed	O
overexpression	O
of	O
several	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
activating	O
genes	I:C0017337
and	O
DPYD	O
downregulation	O
deduce	O
that	O
chemotherapy	B:C3665472
naïve	O
colorectal	I:C0009404
tumors	I:C0009404
share	O
favorable	O
gene	O
expression	O
profile	O
for	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
therapy	O
.	O

The	O
observed	O
overexpression	O
of	O
several	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
activating	O
genes	I:C0017337
and	O
DPYD	O
downregulation	O
deduce	O
that	O
chemotherapy	O
naïve	B:C0009404
colorectal	I:C0009404
tumors	I:C0009404
share	O
favorable	O
gene	O
expression	O
profile	O
for	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
therapy	O
.	O

The	O
observed	O
overexpression	O
of	O
several	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
activating	O
genes	I:C0017337
and	O
DPYD	O
downregulation	O
deduce	O
that	O
chemotherapy	O
naïve	O
colorectal	I:C0009404
tumors	I:C0009404
share	O
favorable	O
gene	O
expression	O
profile	O
for	O
5	B:C0016360
-	I:C0016360
fluorouracil	I:C0016360
therapy	O
.	O

The	O
observed	O
overexpression	O
of	O
several	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
activating	O
genes	I:C0017337
and	O
DPYD	O
downregulation	O
deduce	O
that	O
chemotherapy	O
naïve	O
colorectal	I:C0009404
tumors	I:C0009404
share	O
favorable	O
gene	O
expression	O
profile	O
for	O
5	O
-	I:C0016360
fluorouracil	I:C0016360
therapy	B:C0087111
.	O

Low	O
RRM2	B:C1335649
transcript	O
and	O
UPB1	O
methylation	O
levels	O
present	O
separate	O
poor	O
prognosis	O
factors	I:C1514474
for	O
colorectal	O
carcinoma	I:C0009402
patients	O
and	O
should	O
be	O
further	O
investigated	O
.	O

Low	O
RRM2	O
transcript	B:C1519595
and	O
UPB1	O
methylation	O
levels	O
present	O
separate	O
poor	O
prognosis	O
factors	I:C1514474
for	O
colorectal	O
carcinoma	I:C0009402
patients	O
and	O
should	O
be	O
further	O
investigated	O
.	O

Low	O
RRM2	O
transcript	O
and	O
UPB1	B:C1424165
methylation	O
levels	O
present	O
separate	O
poor	O
prognosis	O
factors	I:C1514474
for	O
colorectal	O
carcinoma	I:C0009402
patients	O
and	O
should	O
be	O
further	O
investigated	O
.	O

Low	O
RRM2	O
transcript	O
and	O
UPB1	O
methylation	B:C0376452
levels	O
present	O
separate	O
poor	O
prognosis	O
factors	I:C1514474
for	O
colorectal	O
carcinoma	I:C0009402
patients	O
and	O
should	O
be	O
further	O
investigated	O
.	O

Low	O
RRM2	O
transcript	O
and	O
UPB1	O
methylation	O
levels	O
present	O
separate	O
poor	O
prognosis	B:C1514474
factors	I:C1514474
for	O
colorectal	O
carcinoma	I:C0009402
patients	O
and	O
should	O
be	O
further	O
investigated	O
.	O

Low	O
RRM2	O
transcript	O
and	O
UPB1	O
methylation	O
levels	O
present	O
separate	O
poor	O
prognosis	O
factors	I:C1514474
for	O
colorectal	B:C0009402
carcinoma	I:C0009402
patients	O
and	O
should	O
be	O
further	O
investigated	O
.	O

